AVH — AVITA Medical Balance Sheet
0.000.00%
- AU$160.31m
- AU$201.22m
- $64.25m
Annual balance sheet for AVITA Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 73.6 | 111 | 79.3 | 89.1 | 35.9 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2.51 | 7.88 | 4.96 | 7.94 | 11.8 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 78.4 | 121 | 87.5 | 104 | 57 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 3.71 | 2.94 | 2.05 | 4.32 | 13.6 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 82.5 | 126 | 98.3 | 112 | 79.7 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 7.71 | 7.39 | 10.7 | 13.2 | 20.2 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 10.1 | 9.85 | 13.5 | 62.6 | 75.2 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 72.4 | 116 | 84.7 | 49.1 | 4.5 |
| Total Liabilities & Shareholders' Equity | 82.5 | 126 | 98.3 | 112 | 79.7 |
| Total Common Shares Outstanding |